The current emergence of monkeypox: The recurrence of another smallpox?

Peer-Reviewed Publication

COMPUSCRIPT LTD

https://doi.org/10.1016/j.bsheal.2022.09.004

 

Since its first confirmation in London on 12 May 2022, many monkeypox cases have been reported worldwide. Noticeably, the epidemiology, pathology, and clinical features of the current emergence have been compared to those of smallpox, a severe contagious disease historically epidemic worldwide for nearly 3,000 years. However, some characteristics of the present outbreak differed from those of previous monkeypox outbreaks. The authors of this article consider if this emergence of monkeypox could cause another global pandemic similar to smallpox or influenza or if it is only the re-emergence of a new strain. To address these questions, they reviewed its virology, transmission, clinical characteristics, experimental diagnosis, and prevention and intervention.

 

Keywords: Monkeypox, Epidemiology, Clinical characteristics, Vaccine, Drugs, Biosafety

 

# # # # # #

 

Biosafety and Health is sponsored by the Chinese Medical Association, managed by National Institute for Viral

Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC).

For more information, please visit https://www.journals.elsevier.com/biosafety-and-health

Editorial Board: https://www.sciencedirect.com/journal/biosafety-and-health/about/editorial-board

Biosafety and Health is available on ScienceDirect (https://www.sciencedirect.com/journal/biosafety-and-health).

Submissions to Biosafety and Health may be made using Editorial Manager®

(https://www.editorialmanager.com/bsheal/default.aspx).

CiteScore: 4.8

ISSN 2590-0536

 

# # # # # #

 

Article reference: Tianyu Lu, Zongzhen Wu, Shibo Jiang, Lu Lu, Huan Liu, The current emergence of monkeypox: The recurrence of another smallpox?, Biosafety and Health, 2022, ISSN 2590-0536, https://doi.org/10.1016/j.bsheal.2022.09.004

---

JOURNAL

Biosafety and Health

DOI

10.1016/j.bsheal.2022.09.004